Mecanismos de señalización celular en enfermedades hepáticas, cardiovasculares y cáncer
Heidelberg University
Heidelberg, AlemaniaPublicacions en col·laboració amb investigadors/es de Heidelberg University (10)
2019
-
Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body
Cell, Vol. 179, Núm. 7, pp. 1661-1676.e19
2018
-
Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in DDC-induced cholestatic liver injury
Liver International, Vol. 38, Núm. 9, pp. 1664-1675
-
PHD3 controls lung cancer metastasis and resistance to EGFR inhibitors through TGFa
Cancer Research, Vol. 78, Núm. 7, pp. 1805-1819
2017
-
BMP-9 interferes with liver regeneration and promotes liver fibrosis
Gut, Vol. 66, Núm. 5, pp. 939-954
-
The level of caveolin-1 expression determines response to TGF-β as a tumour suppressor in hepatocellular carcinoma cells
Cell Death and Disease, Vol. 8, Núm. 10
2016
-
TGF-β signalling and liver disease
FEBS Journal, pp. 2219-2232
-
TGF-β1 and TGF-β2 abundance in liver diseases of mice and men
Oncotarget, Vol. 7, Núm. 15, pp. 19499-19518
-
The rationale for targeting TGF-β in chronic liver diseases
European Journal of Clinical Investigation, Vol. 46, Núm. 4, pp. 349-361
2015
-
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis: Updated
Current Pathobiology Reports, Vol. 3, Núm. 4, pp. 291-305
2014
-
Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases
International Journal of Molecular Sciences, Vol. 15, Núm. 4, pp. 5199-5220